A Laborde1, R Nicot2, T Wojcik3, J Ferri4, G Raoul4. 1. CHU de Lille, Hôpital Roger-Salengro, Oral and Maxillofacial Surgery Department, 59000 Lille, France; Université Lille Nord de France, UDSL, 59000 Lille, France. Electronic address: amelyla@hotmail.com. 2. CHU de Lille, Hôpital Roger-Salengro, Oral and Maxillofacial Surgery Department, 59000 Lille, France; Université Lille Nord de France, UDSL, 59000 Lille, France. 3. Centre Oscar-Labret, Head and Neck Department, 59000 Lille, France; Inserm U 1008, Controlled Drug Delivery Systems and Biomaterials, 59000 Lille, France; International Association of Oral and Maxillofacial Medecine (IAOMM), 7, bis rue de la créativité, 59650 Villeneuve d'Asq, France. 4. CHU de Lille, Hôpital Roger-Salengro, Oral and Maxillofacial Surgery Department, 59000 Lille, France; Université Lille Nord de France, UDSL, 59000 Lille, France; Inserm U 1008, Controlled Drug Delivery Systems and Biomaterials, 59000 Lille, France; International Association of Oral and Maxillofacial Medecine (IAOMM), 7, bis rue de la créativité, 59650 Villeneuve d'Asq, France.
Abstract
INTRODUCTION: Ameloblastoma is a rare, benign odontogenic tumour associated with a high recurrence rate. It accounts for 1% of all tumours of the jaws. The purpose of this study was to compare the ameloblastoma recurrence rate according to the type of treatment: radical or conservative. PATIENTS AND METHODS: All patients with a diagnosis of ameloblastoma between 1991 and 2013 were retrospectively identified in order to extract topographic, radiological, and histological data and the type of treatment: conservative (marsupialization, enucleation, curettage) or radical (segmental resection) and to compare the recurrence rate according to the type of treatment. RESULTS: Twenty-seven patients were included, managed by conservative treatment (CT) in 22 cases and radical treatment (RT) in 14 cases. The recurrence rate was 90.9% in the CT group and 9.1% in the RT group (P=0.025) with a mean follow-up of 56.2 months. DISCUSSION: The recurrence rate after conservative treatment was higher than that after radical treatment. These results are similar to those reported in the literature. The choice of treatment must be adapted to the macroscopic and histological characteristics of each tumour and to the patient.
INTRODUCTION:Ameloblastoma is a rare, benign odontogenic tumour associated with a high recurrence rate. It accounts for 1% of all tumours of the jaws. The purpose of this study was to compare the ameloblastoma recurrence rate according to the type of treatment: radical or conservative. PATIENTS AND METHODS: All patients with a diagnosis of ameloblastoma between 1991 and 2013 were retrospectively identified in order to extract topographic, radiological, and histological data and the type of treatment: conservative (marsupialization, enucleation, curettage) or radical (segmental resection) and to compare the recurrence rate according to the type of treatment. RESULTS: Twenty-seven patients were included, managed by conservative treatment (CT) in 22 cases and radical treatment (RT) in 14 cases. The recurrence rate was 90.9% in the CT group and 9.1% in the RT group (P=0.025) with a mean follow-up of 56.2 months. DISCUSSION: The recurrence rate after conservative treatment was higher than that after radical treatment. These results are similar to those reported in the literature. The choice of treatment must be adapted to the macroscopic and histological characteristics of each tumour and to the patient.
Authors: Yuri Slusarenko da Silva; Natalia Aguiar Tartaroti; Daniel Isaac Sendyk; Maria Cristina Zindel Deboni; Maria da Graça Naclério-Homem Journal: Oral Maxillofac Surg Date: 2018-09-06
Authors: Liam Robinson; Chané Smit; Felipe Paiva Fonseca; Aline Corrêa Abrahão; Mário José Romañach; Syed Ali Khurram; Keith D Hunter; Paul M Speight; Willie F P van Heerden Journal: Head Neck Pathol Date: 2022-07-21